FARINA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.078
EU - Europa 2.366
AS - Asia 2.251
SA - Sud America 304
AF - Africa 34
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9.048
Nazione #
US - Stati Uniti d'America 4.016
SG - Singapore 955
CN - Cina 544
RU - Federazione Russa 527
IE - Irlanda 498
DE - Germania 259
BR - Brasile 253
IT - Italia 230
TR - Turchia 220
HK - Hong Kong 204
SE - Svezia 203
VN - Vietnam 198
GB - Regno Unito 152
UA - Ucraina 132
FI - Finlandia 111
FR - Francia 103
CA - Canada 35
IN - India 34
CZ - Repubblica Ceca 31
BE - Belgio 20
PL - Polonia 20
AR - Argentina 18
JP - Giappone 18
AT - Austria 16
ES - Italia 16
NL - Olanda 16
ZA - Sudafrica 16
MX - Messico 15
BD - Bangladesh 12
KR - Corea 11
EC - Ecuador 9
IQ - Iraq 9
LT - Lituania 9
UZ - Uzbekistan 8
EU - Europa 7
UY - Uruguay 7
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EG - Egitto 5
DZ - Algeria 4
ID - Indonesia 4
MA - Marocco 4
VE - Venezuela 4
BY - Bielorussia 3
CL - Cile 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
DO - Repubblica Dominicana 2
IL - Israele 2
JO - Giordania 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SA - Arabia Saudita 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
CR - Costa Rica 1
ET - Etiopia 1
GN - Guinea 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 9.048
Città #
Singapore 576
Jacksonville 511
Chandler 504
Dublin 498
San Jose 440
Dallas 348
Ashburn 246
Hong Kong 200
Boardman 174
Santa Clara 169
New York 113
Council Bluffs 101
Izmir 101
The Dalles 97
Nanjing 96
Beijing 93
Wilmington 83
San Mateo 79
Moscow 77
Lawrence 67
Princeton 67
Ho Chi Minh City 65
Munich 64
Lauterbourg 53
Ann Arbor 52
Los Angeles 43
Dearborn 42
L'aquila 41
Milan 38
Nanchang 37
Hanoi 32
Shenyang 31
Turku 29
Brno 28
Verona 27
São Paulo 25
Hefei 24
Frankfurt am Main 23
Helsinki 23
Woodbridge 23
Hebei 22
Seattle 21
Tianjin 21
Brussels 20
Dong Ket 20
Falls Church 20
Warsaw 19
Tokyo 18
Des Moines 17
Rome 17
Shanghai 17
Orem 16
Jinan 15
Montreal 15
Chennai 14
Columbus 14
L’Aquila 14
Mountain View 14
Nuremberg 14
Boston 13
Bremen 13
Brooklyn 13
Denver 13
Jiaxing 12
Johannesburg 12
Stockholm 12
Guangzhou 11
Toronto 11
Kunming 10
Norwalk 10
Auburn Hills 9
Changsha 9
Philadelphia 9
Falkenstein 8
London 8
Rio de Janeiro 8
Amsterdam 7
Ankara 7
Atlanta 7
Hangzhou 7
Hải Dương 7
Ningbo 7
Phoenix 7
Poplar 7
Salvador 7
Campinas 6
Curitiba 6
Da Nang 6
Houston 6
Impruneta 6
Kitzingen 6
Manchester 6
Montevideo 6
San Francisco 6
Taizhou 6
Tashkent 6
West Jordan 6
Biên Hòa 5
Brasília 5
Lanzhou 5
Totale 5.999
Nome #
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 182
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 172
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 168
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 164
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 160
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 154
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 150
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. 145
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 144
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 143
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 140
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 140
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 138
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 138
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 137
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements 136
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 134
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 133
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 133
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 132
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 131
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 130
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer 129
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 128
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 128
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients 128
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 125
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 124
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 122
TRASFORMING GROWTH FACTOR-BETA 1 ENHANCES THE INVASIVITY OF HUMAN MDBA-MB-231 BREAST CANCER CELLS BY UP REGULATING UROKINASE ACTIVITY 120
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 119
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 119
T-cell restricted and unrestricted expression of transfected human interleukin-2 gene: phorbol ester- and calcium-inducible versus constitutive expression. 119
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: A pilot study 116
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 116
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 114
fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. 113
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 112
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 112
Alternative TrkA splicing and neuroblastoma 111
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 110
TrkAIII expression in the thymus 110
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 110
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens. 109
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 109
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 109
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 107
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 107
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. 106
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. 105
CELL-SPECIFIC BIFUNCTIONAL ROLE OF JUN ONCOGENE FAMILY MEMBERS ON GLUCOCORTICOID RECEPTOR-DEPENDENT TRANSCRIPTION 105
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 104
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 104
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. 102
POSITIVE AND NEGATIVE REGULATION OF THE COMPOSITE OCTAMER MOTIF OF THE INTERLEUKIN 2 ENHANCER BY AP-1, OCT-2, AND RETINOIC ACID RECEPTOR 102
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 102
Thioredoxin inhibits microvascular endothelial capillary tubule formation 102
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 101
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 101
Alternative TrkA splicing and Cancer 99
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. 99
TRANSCRIPTIONAL MODULATION OF THE HUMAN INTERCELLULAR ADHESION MOLECULE GENE I (ICAM-1) BY RETINOIC ACID IN MELANOMA CELLS 97
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 95
AN EARLY RESPONSE OF AN AP1-JUND COMPLEX DURING T-CELL ACTIVATION 95
AUTOIMMUNE ANTIGEN KU IS ENRICHED ON OLIGONUCLEOTIDE COLUMNS DISTINCT FROM THOSE CONTAINING THE OCTAMER BINDING PROTEINDNA CONSENSUS SEQUENCE 95
Alternative TrkAIII splicing and Cancer 94
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced Death of SH-SY5Y Neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, whitin the context of a tumour stem cell-like phenotype 94
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 88
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 88
The Alternative TrkAIII splice variant by neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 88
GLUCORTICOID RECEPTOR-MEDIATED SUPPRESSION OF THE INTERLEUKIN 2 GENE EXPRESSION THROUGH IMPAIRMENT OF THE COOPERATIVITY BETWEEN NUCLEAR FACTOR OF ACTIVATED T CELLS AND AP-1 ENHANCER ELEMENTS 87
Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer. 85
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 84
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 82
THE KU COMPLEX IS MODULATED IN RESPONSE TO VIRAL INFECTION AND OTHER CELLULAR CHANGES 82
Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. 82
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 76
PROSTAGLANDIN E2 INHIBITS THE INTERLEUKIN-2 PROMOTER ACTIVITY THROUGH DOWN-REGULATION OF THE OCT-DEPENDENT TRANSCRIPTION OF THE OCTAMER MOTIF 72
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 65
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 48
Jurkat T-Cell Antigen-Independent Elimination of PMA-Activated Neuroblastoma Cells Is Triggered by CCL2/CCR2, Depends Upon Lipid Raft LFA1/ICAM1 Immune Synapses, Is Mediated by m-TRAIL and Is Augmented by the TrkAIII Oncoprotein 30
null 5
Totale 9.194
Categoria #
all - tutte 37.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 0 0 0 0 0 0 0 0 114 41
2021/2022451 33 36 73 27 26 13 12 26 23 11 35 136
2022/20231.419 94 97 35 148 128 148 3 70 629 5 31 31
2023/2024373 47 16 37 41 25 103 1 5 5 12 7 74
2024/20251.643 39 25 134 86 197 134 282 116 291 99 123 117
2025/20263.193 140 303 260 453 347 226 511 100 288 435 130 0
Totale 9.194